Your browser doesn't support javascript.
loading
The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity.
Chang, Ki-Eun; Wei, Bih-Rong; Madigan, James P; Hall, Matthew D; Simpson, R Mark; Zhuang, Zhengping; Gottesman, Michael M.
Afiliación
  • Chang KE; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Wei BR; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Madigan JP; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Hall MD; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Simpson RM; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Zhuang Z; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland.
  • Gottesman MM; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. mgottesman@nih.gov.
Mol Cancer Ther ; 14(1): 90-100, 2015 Jan.
Article en En | MEDLINE | ID: mdl-25376608

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Piperazinas / Cisplatino / Compuestos Bicíclicos Heterocíclicos con Puentes / Proteína Fosfatasa 2 Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Piperazinas / Cisplatino / Compuestos Bicíclicos Heterocíclicos con Puentes / Proteína Fosfatasa 2 Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2015 Tipo del documento: Article